IL10 and colitis: CBC (0.001–1 μM) exhibited promising anti‐inflammatory effects in an in vitro model of colitis, decreasing LPS increased nitrite levels and attenuating IFN‐γ and IL‐10 secretion in peritoneal macrophages (Romano et al., 2013).